Varicella-zoster and herpes simplex virus reactivation post-COVID-19 vaccination: a review of 40 cases in an International Dermatology Registry
Recommended Citation
Fathy RA, McMahon DE, Lee C, Chamberlin GC, Rosenbach M, Lipoff JB, Tyagi A, Desai SR, French LE, Lim HW, Thiers BH, Hruza GJ, Fassett M, Fox LP, Greenberg HL, Blumenthal K, and Freeman EE. Varicella Zoster and Herpes Simplex Virus Reactivation Post-COVID-19 Vaccination: A Review of 40 Cases in an International Dermatology Registry. J Eur Acad Dermatol Venereol 2021.
Document Type
Article
Publication Date
9-6-2021
Publication Title
Journal of the European Academy of Dermatology and Venereology
Abstract
Since December 2020, the American Academy of Dermatology and the International League of Dermatologic Societies' COVID-19 Dermatology Registry has tracked dermatologic reactions post-COVID-19 vaccination. Within months, a variety of cutaneous manifestations were reported after the Moderna and Pfizer-BioNTech COVID-19 vaccines.(1) As of April 2021, a total of 672 possible vaccine-related skin reactions have been reported by healthcare providers. Here, we evaluate the first 40 cases of varicella zoster virus (VZV) and herpes simplex virus (HSV) reported in the registry after COVID-19 vaccination with either the Moderna or Pfizer-BioNTech vaccines.
PubMed ID
34487581
ePublication
ePub ahead of print
